I think at top shops the answer is yes.

I have a friend at GS ER and he told me that he keeps on getting emails from head hunters

 

heard Mercury is a scam - any other HH that is willing to talk to SS ER?

 

What kind of offer would you accept? Since you are anonymous, I'd be interested in hearing your whole thought process on what it would take for you to leave

 
Most Helpful

A few things to your question - I know SS ER gets a lot of hate sometimes, but I'm relatively junior into my career covering a hot sector. Outside of money being great (benchmarking against some of the posts here, I think I'm getting more than usual with ~1YOE and TC ~200K) and my analyst being a good person, I don't think I know my sector well enough to generate that much value for the buy-side. I also like my work and the client interactions I've had as an associate so far. 

For the buy-side, I know it's all about performance in the end, but I think I'll be in a much stronger position if I give myself a few more years - still lots to learn/room for comp growth. Of course, I might be biased in this area because I've always worked for very good analysts; I'm currently on a ranked team, and started off at an independent that mimicked the buy-side. Sometimes I think people from SS jump to the buy-side too quickly without discerning fund quality/platform stability, which is fine, but it's easy to get blown out. Personally, I've seen a few associates lasting just a year before going back to SS + a slight downgrade. For now, I like the stability of my job and the brand name on my resume. Ideally, after a few years, I'd leave for LO or VC, but would be open if these opportunities present themselves earlier (I've gotten some traction with VCs early on). I'm also not opposed to staying in SS ER either and becoming an analyst, simply because of how much growth my sector has (in case someone asks, it's HC but not biotech). Hope this helps!

 

Neque hic suscipit aut sed. Ullam reiciendis unde laborum. Quia id cum ipsam aut provident maxime saepe ipsa.

Id tempora voluptatem tenetur fuga. Ratione veritatis qui quo veniam harum ipsa quia. Sint ut non quas. Exercitationem rerum minus et aut.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
DrApeman's picture
DrApeman
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”